Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05884307
Collaborator
(none)
100
1
1
30
101.5

Study Details

Study Description

Brief Summary

The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 1 is a feasibility and acceptability study of the proposed intervention and will enroll 100 TNB participants to provide feedback to inform a follow-up randomized controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Other: Trans Care Web App
N/A

Detailed Description

The overall purpose of this project is to create a free intervention that can be disseminated widely throughout TNB communities to improve well-being in an easy, accessible way.

Development and execution of the Trans Care intervention involves two primary aims:
  • Aim 1) Feasibility and acceptability analysis (FAA) [represented by this study record]

  • Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy [to be registered to a separate study record]

Aim 1 involves qualitative and quantitative feedback regarding the content of the Trans Care intervention modules, impact on TNB participants well-being, and feasibility and acceptability of Trans Care intervention. Results from the FAA study will then be analyzed and presented to our community partners who will help us develop modifications to Trans Care to increase its efficacy and ease of use.

Aim 1 Hypotheses:
  • The investigators expect that qualitative responses from participants in the FAA study overall will reflect that the Trans Care intervention was feasible and helpful. Any proposed changes from participants' qualitative responses will be incorporated into the final Trans Care intervention presented in the RCT.

  • The investigators expect that participants in the FAA study will endorse high scores three scale assessment of feasibility and acceptability.

Aim 1 Endpoints:

The primary endpoint of the study is to determine if the Trans Care intervention is feasible and helpful to TNB individuals for improving their coping strategies. This will be determined through qualitative prompts and a quantitative measure of feasibility and acceptability.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
Anticipated Study Start Date :
Apr 1, 2024
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Trans and Nonbinary Adults

Other: Trans Care Web App
an educational and interactive website designed to improve coping strategies of TNB individuals

Outcome Measures

Primary Outcome Measures

  1. Acceptability of Intervention Measure (AIM) Score [post intervention (intervention can take up to 3 hours to complete, participant has up to 1 week to complete it)]

    The AIM is a 4-item measure of intervention acceptability, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total mean scores range from 1 - 5, higher scores indicate higher acceptability.

  2. Intervention Appropriateness Measure (IAM) Score [post intervention (intervention can take up to 3 hours to complete, participant has up to 1 week to complete it)]

    IAM is a 4-item measure of intervention appropriateness, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. A total mean score ranges from 1 - 5, higher scores indicate higher appropriateness.

  3. Feasibility of Intervention Measure (FIM) Score [post intervention (intervention can take up to 3 hours to complete, participant has up to 1 week to complete it)]

    FIM is a 4-item measure of intervention feasibility, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable, with a total mean score ranging from 1 to 5, higher scores indicate higher feasibility.

  4. Summary of Qualitative Prompts [post intervention (intervention can take up to 3 hours to complete, participant has up to 1 week to complete it)]

    Participants will be given four prompts to qualitatively assess their experience with the intervention. What you liked most? What would you change? What was most helpful? and What was least helpful? Thematic analysis will be conducted to analyze participants' responses to determine predominant changes suggested by participants

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Identify as transgender, transsexual, nonbinary, and/or have a transgender history.

  • Experience gender dysphoria.

  • Time available to commit to completing a 2-3-hour online intervention and 1-2 hours to complete follow up surveys

Exclusion Criteria:
  • under 18 years old

  • individual does not identify as transgender, transsexual, nonbinary, and/or have a transgender history

  • does not experience gender dysphoria

  • is unable to commit to the time requirements of the study

  • does not have access to an internet compatible device

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Wisconsin Madison Wisconsin United States 53705

Sponsors and Collaborators

  • University of Wisconsin, Madison

Investigators

  • Principal Investigator: Stephanie Budge, PhD, LP, University of Wisconsin, Madison

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT05884307
Other Study ID Numbers:
  • 2023-0644: FAA
  • UW Baldwin Endowment
First Posted:
Jun 1, 2023
Last Update Posted:
Jun 2, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Wisconsin, Madison
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2023